JAK2 and osteosarcoma: Recent research found that miR-19 could activate JAK2/STAT3 signaling pathway via silencing SOCS6 and in osteosarcoma and promote osteosarcoma growth in vitro and in vivo, including the reduction of G1-S arrest and an increase of the S phase36.